Clinical Trials

Acetazolamide Efficacy in Ataxia in PMM2-CDG – Mayo Clinic The primary objective is to determine the efficacy of acetazolamide in improving ataxia in patients with PMM2-CDG. This study is double-blind, placebo-controlled, 1:1 randomized clinical therapeutic trial of acetazolamide for the treatment of ataxia in patients with PMM2-CDG.  Contacts: Kaitlin Schwartz, B.S 507-293-9114 Oral Epalrestat … Continue reading Clinical Trials